mKIAA1853 Activators encompass a spectrum of chemical compounds that, through various mechanisms, enhance the functional activity of mKIAA1853, a protein involved in specific cellular processes. Forskolin, by increasing cAMP levels, indirectly facilitates mKIAA1853 function through PKA activation, which may phosphorylate proteins that interact with mKIAA1853, enhancing its activity. Similarly, Epigallocatechin gallate, a kinase inhibitor, may streamline signaling pathways by inhibiting competitive pathways, allowing for a more pronounced role of mKIAA1853 in its specific cellular functions. Isoproterenol, another cAMP-elevating agent through beta-adrenergic receptor stimulation, and PMA, a PKC activator, both enhance mKIAA1853 activity by promoting phosphorylation events that can modulate the protein's function. LY294002, by inhibiting PI3K, may shift the balance of intracellular signaling in favor of pathways involving mKIAA1853, while Sphingosine-1-phosphate, through its receptor-mediated signaling, could enhance the protein's activity by influencing related pathways.
Additionally, A23187, known as Calcimycin, raises intracellular calcium levels, potentially enhancing mKIAA1853's activity by activating calcium-dependent signaling mechanisms. Staurosporine, although a broad-spectrum kinase inhibitor, may indirectly favor mKIAA1853's activity by altering the phosphorylation landscape within the cell. The ROCK inhibitor Y-27632 could facilitate changes in the cytoskeleton, thereby potentially augmenting mKIAA1853's interactions with cellular structures and enhancing its function. Genistein, by inhibiting tyrosine kinases, could potentiate mKIAA1853's role by minimizing competing tyrosine kinase signals. Thapsigargin, a SERCA pump inhibitor, disrupts calcium homeostasis, which can lead to activation of signaling pathways that enhance mKIAA1853's function. Lastly, Nicotine's modulation of intracellular signals may indirectly lead to upregulation of mKIAA1853, influencing gene expression and cellular processes where mKIAA1853 is a critical player.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin raises intracellular cAMP levels, indirectly enhancing mKIAA1853 activity by activating protein kinase A (PKA), which may phosphorylate substrates that interact with or regulate mKIAA1853. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, increases cAMP levels, thereby enhancing mKIAA1853 activity via PKA-mediated phosphorylation pathways that interact with mKIAA1853. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
As a kinase inhibitor, Epigallocatechin gallate reduces the activity of competitive pathways, allowing mKIAA1853's role in specific cellular functions to be more pronounced. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA, an activator of protein kinase C (PKC), modulates phosphorylation events that can influence mKIAA1853's activity by affecting proteins that regulate or are regulated by mKIAA1853. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor that shifts the balance of intracellular signaling to favor pathways in which mKIAA1853 is involved, potentially enhancing its functional activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Sphingosine-1-phosphate engages its receptors to activate downstream signaling pathways that could enhance mKIAA1853's activity in related cellular processes. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 raises intracellular calcium levels, potentially enhancing mKIAA1853's activity through calcium-dependent signaling mechanisms that mKIAA1853 is part of. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine, a nonspecific kinase inhibitor, may indirectly upregulate mKIAA1853 activity by modulating the phosphorylation of proteins that interact with mKIAA1853. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
The ROCK inhibitor Y-27632 facilitates changes in the cytoskeleton, potentially enhancing mKIAA1853's interactions with cellular structures and augmenting its function. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that could potentiate mKIAA1853's activity by reducing the competitive signals from tyrosine kinase pathways that mKIAA1853 is involved in. |